Therapeutic and Radiosensitizing Effects of Armillaridin on Human Esophageal Cancer Cells

Figure 3

Effect of Armillaridin on mitochondrial transmembrane potential reduction, apoptosis, and caspase inhibitor activity in CE81T/VGH cells. (a) Representative mitochondrial transmembrane potential histograms were shown as CE81T/VGH cells treated with Armillaridin for 24 hours. (b) Relative level of mitochondrial transmembrane potential. (c) The amount of cells with early apoptosis (FITC⁺/PI⁻ cells) by the Annexin V/PI staining assay. (d) Caspase 3 activity with or without pretreatment with pan caspase inhibitor at day 1 (closed column) and day 2 (opened column). Results are mean ± SE from three independent experiments. Significant differences between control cells and cells treated with AM 20 𝜇M are indicated by *𝑃<0.001. AM: Armillaridin.

(a)

(b)

(c)

(d)